TrialAmerican journal of medical genetics. Part A2017

Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open-label, phase 2 study.

Paul R Harmatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.